Concepedia

Arvin Iracheta‐Vellve

AI

30

Publications

4.3K

Citations

28

H-Index

2012

Active since

Affiliations

University of Massachusetts Chan Medical School(Current)

Harvard University

Massachusetts General Hospital

Broad Institute

Dana-Farber Cancer Institute

Arvin Iracheta‐Vellve is an author at University of Massachusetts Chan Medical School specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2012–2024

30

Publications

30

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 688 citations · Full text

, , +8

STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease

Jan Petrášek, Arvin Iracheta‐Vellve, Tímea Csák et al. · Proceedings of the National Academy of Sciences · 2013 · 442 citations · Full text

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve et al. · Nature · 2021 · 339 citations · Full text

, , +6

Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol‐Induced Liver Damage, Steatosis, and Inflammation in Mice

Aditya Ambade, Patrick Lowe, Karen Kodys et al. · Hepatology · 2018 · 213 citations

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker et al. · Nature Immunology · 2022 · 198 citations

, , +10

Rows per page

1–5 of 30